Interestingly, the evidence for cyclooxygenase-2 (COX-2) inhibitors has pointed in another direction and indicates a protective role against progression towards severe AP, as reported in the same meta-analysis [33]. The gene discussed is PTGS2; the disease is alkaline phosphatase measurement.